Chronic cocaine treatment alters dendritic arborization in the adult motor cortex through a CB1 cannabinoid receptor–dependent mechanism

The CB1 cannabinoid receptors modulate the addictive processes associated with different drugs of abuse, including psychostimulants. Mice lacking CB1 receptors exhibit an important attenuation of the reinforcing responses produced by cocaine in an operant self-administration paradigm. We have investigated the effect of chronic cocaine treatment on dendrite structure and spine density of the principal cortical neuron, the pyramidal neuron, in CB1 knockout mice and wild type littermates. Layer III pyramidal cells of the motor cortex were injected intracellularly in fixed cortical slices and their morphometric parameters analyzed. Under basal conditions, the field area of the dendritic arbors was more extensive and dendritic spine density was higher in wild type mice than in CB1 knockout mice. Chronic treatment of cocaine diminished the size and length of the basal dendrites and spine density on pyramidal cells from wild type mice. However, the total number of spines in the pyramidal cells of CB1 knockout mice augmented slightly following chronic cocaine treatment, although no changes in the morphology of the dendritic arbor were observed. Our data demonstrate that microanatomy and synaptic connectivity are affected by cocaine, the magnitude and nature of these changes depend on the presence of CB1 receptors.

[1]  J. Eayrs,et al.  Postnatal development of the cerebral cortex in the rat. , 1959, Journal of anatomy.

[2]  J. Cheer,et al.  Modification of 5-HT2 receptor mediated behaviour in the rat by oleamide and the role of cannabinoid receptors , 1999, Neuropharmacology.

[3]  Bryan Kolb,et al.  Alterations in the morphology of dendrites and dendritic spines in the nucleus accumbens and prefrontal cortex following repeated treatment with amphetamine or cocaine , 1999, The European journal of neuroscience.

[4]  O. Valverde,et al.  Early age-related cognitive impairment in mice lacking cannabinoid CB1 receptors , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[5]  R. R. Sturrock,et al.  Problems of the Keimbahn: New Work on Mammalian Germ Cell Lineage , 1985 .

[6]  V. Marzo,et al.  The endocannabinoid system in the basal ganglia and in the mesolimbic reward system: implications for neurological and psychiatric disorders , 2003 .

[7]  S. Esteban,et al.  Ethanol desensitizes cannabinoid CB1 receptors modulating monoamine synthesis in the rat brain in vivo , 2006, Neuroscience Letters.

[8]  G. Elston Cortex, cognition and the cell: new insights into the pyramidal neuron and prefrontal function. , 2003, Cerebral cortex.

[9]  M. Parmentier,et al.  Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. , 1999, Science.

[10]  K. Mackie,et al.  Redistribution of CB1 cannabinoid receptors during evolution of cholinergic basal forebrain territories and their cortical projection areas: A comparison between the gray mouse lemur (Microcebus murinus, primates) and rat , 2005, Neuroscience.

[11]  G. Elston,et al.  The occipitoparietal pathway of the macaque monkey: comparison of pyramidal cell morphology in layer III of functionally related cortical visual areas. , 1997, Cerebral cortex.

[12]  W. Zieglgänsberger,et al.  The endogenous cannabinoid system controls extinction of aversive memories , 2002, Nature.

[13]  K. Hsu,et al.  Repeated cocaine administration promotes long-term potentiation induction in rat medial prefrontal cortex. , 2007, Cerebral cortex.

[14]  G. Marsicano,et al.  Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain , 1999, The European journal of neuroscience.

[15]  V. Watts,et al.  D 2 Dopamine Receptors Modulate G-Subunit Coupling of the CB 1 Cannabinoid Receptor , 2004 .

[16]  K. Johnson,et al.  Neurobiology of cocaine abuse. , 1992, Trends in pharmacological sciences.

[17]  Bryan Kolb,et al.  Amphetamine or cocaine limits the ability of later experience to promote structural plasticity in the neocortex and nucleus accumbens , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[18]  A. Grace,et al.  The roles of cannabinoid and dopamine receptor systems in neural emotional learning circuits: implications for schizophrenia and addiction , 2006, Cellular and Molecular Life Sciences CMLS.

[19]  R. Christopher Pierce,et al.  A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants , 1997, Brain Research Reviews.

[20]  I. Sora,et al.  Cocaine, reward, movement and monoamine transporters , 2002, Molecular Psychiatry.

[21]  M. Glass,et al.  Concurrent Stimulation of Cannabinoid Cb1 and Dopamine D2 Receptors Augments Camp Accumulation in Striatal Neurons: Evidence for a G S Linkage to the Cb1 Receptor , 1997 .

[22]  V. Watts,et al.  D2 Dopamine Receptors Modulate Gα-Subunit Coupling of the CB1 Cannabinoid Receptor , 2004, Journal of Pharmacology and Experimental Therapeutics.

[23]  J. DeFelipe,et al.  The pyramidal neuron of the cerebral cortex: Morphological and chemical characteristics of the synaptic inputs , 1992, Progress in Neurobiology.

[24]  J. Arnold The role of endocannabinoid transmission in cocaine addiction , 2005, Pharmacology Biochemistry and Behavior.

[25]  O. Valverde,et al.  Involvement of the endocannabinoid system in drug addiction , 2006, Trends in Neurosciences.

[26]  D. Fortin,et al.  Endocannabinoid signalling selectively targets perisomatic inhibitory inputs to pyramidal neurones in juvenile mouse neocortex , 2004, The Journal of physiology.

[27]  T. Woolsey,et al.  Structure of layer IV in the somatosensory neocortex of the rat: Description and comparison with the mouse , 1974, The Journal of comparative neurology.

[28]  George Paxinos,et al.  The Mouse Brain in Stereotaxic Coordinates , 2001 .

[29]  J. Shumsky,et al.  Prenatal cocaine exposure produces consistent developmental alterations in dopamine-rich regions of the cerebral cortex , 2001, Neuroscience.

[30]  J. DeFelipe,et al.  Density and morphology of dendritic spines in mouse neocortex , 2006, Neuroscience.

[31]  M. Herkenham,et al.  Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[32]  B Kolb,et al.  Cocaine self‐administration alters the morphology of dendrites and dendritic spines in the nucleus accumbens and neocortex , 2001, Synapse.

[33]  Alan Peters,et al.  Cellular components of the cerebral cortex , 1984 .

[34]  M. Parmentier,et al.  Involvement of CB1 cannabinoid receptors in emotional behaviour , 2002, Psychopharmacology.

[35]  F. Berrendero,et al.  The endogenous cannabinoid system and brain development , 2000, Trends in Neurosciences.

[36]  Bartlett W. Mel,et al.  Impact of Active Dendrites and Structural Plasticity on the Memory Capacity of Neural Tissue , 2001, Neuron.

[37]  Pat Levitt,et al.  Anatomical abnormalities in dopaminoceptive regions of the cerebral cortex of dopamine D1 receptor mutant mice , 2005, The Journal of comparative neurology.

[38]  M. Kringelbach The human orbitofrontal cortex: linking reward to hedonic experience , 2005, Nature Reviews Neuroscience.

[39]  David Robbe,et al.  Endogenous cannabinoids mediate long-term synaptic depression in the nucleus accumbens , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[40]  F. J. White,et al.  Repeated Cocaine Administration Increases Voltage-sensitive Calcium Currents in Response to Membrane Depolarization in Medial Prefrontal Cortex Pyramidal Neurons , 2022 .

[41]  Rafael Yuste,et al.  Dendritic size of pyramidal neurons differs among mouse cortical regions. , 2006, Cerebral cortex.

[42]  R. Rothman,et al.  Monoamine transporters and psychostimulant drugs. , 2003, European journal of pharmacology.

[43]  N. Darmani,et al.  Behaviorally active doses of the CB1 receptor antagonist SR 141716A increase brain serotonin and dopamine levels and turnover , 2003, Pharmacology Biochemistry and Behavior.

[44]  J. Steketee,et al.  Neurotransmitter systems of the medial prefrontal cortex: potential role in sensitization to psychostimulants , 2003, Brain Research Reviews.

[45]  M. Pistis,et al.  Endocannabinoids Mediate Presynaptic Inhibition of Glutamatergic Transmission in Rat Ventral Tegmental Area Dopamine Neurons through Activation of CB1 Receptors , 2004, The Journal of Neuroscience.

[46]  Bryan Kolb,et al.  Structural plasticity associated with exposure to drugs of abuse , 2004, Neuropharmacology.

[47]  M. Morales,et al.  Cannabinoid CB1 receptor and serotonin 3 receptor subunit A (5‐HT3A) are co‐expressed in GABA neurons in the rat telencephalon , 2004, The Journal of comparative neurology.

[48]  J. Homberg,et al.  A cannabinoid mechanism in relapse to cocaine seeking , 2001, Nature Medicine.

[49]  P. Soubrié,et al.  Improvement of memory in rodents by the selective CB1 cannabinoid receptor antagonist, SR 141716 , 1996, Psychopharmacology.

[50]  O. Valverde Participation of the cannabinoid system in the regulation of emotional-like behaviour. , 2005, Current pharmaceutical design.

[51]  M. Pistis,et al.  Prefrontal Cortex Stimulation Induces 2-Arachidonoyl-Glycerol-Mediated Suppression of Excitation in Dopamine Neurons , 2004, The Journal of Neuroscience.

[52]  A. Lichtman,et al.  Evaluation of CB1 receptor knockout mice in the Morris water maze. , 2002, The Journal of pharmacology and experimental therapeutics.

[53]  R. Roth,et al.  Role for dopamine in the behavioral functions of the prefrontal corticostriatal system: implications for mental disorders and psychotropic drug action. , 2000, Progress in brain research.

[54]  A. Lichtman,et al.  Endocannabinoids in cognition and dependence. , 2002, Prostaglandins, leukotrienes, and essential fatty acids.

[55]  T. Cassano,et al.  Correction for Gobbi et al., Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[56]  P. Skudlarski,et al.  Early age-related cognitive impairment in mice lacking cannabinoid CB 1 receptors , 2005 .

[57]  T. Freund,et al.  Role of endogenous cannabinoids in synaptic signaling. , 2003, Physiological reviews.

[58]  J. Pierri,et al.  Altered cortical glutamate neurotransmission in schizophrenia: evidence from morphological studies of pyramidal neurons. , 2003, Annals of the New York Academy of Sciences.

[59]  B. Gorzalka,et al.  Involvement of the Endocannabinoid System in the Ability of Long-Term Tricyclic Antidepressant Treatment to Suppress Stress-Induced Activation of the Hypothalamic–Pituitary–Adrenal Axis , 2006, Neuropsychopharmacology.

[60]  A. Schoffelmeer,et al.  Cannabinoid CB1 receptors control conditioned drug seeking. , 2005, Trends in pharmacological sciences.

[61]  GUY N. ELSTO,et al.  Cortical heterogeneity : Implications for visual processing and polysensory integration , 2022 .

[62]  Received December Apical Dendritic Spines of the Visual Cortex and Light Deprivation in the Mouse , 1967 .

[63]  G. Paxinos,et al.  Comprar The Mouse Brain in Stereotaxic Coordinates, The coronal plates and diagrams Compact, 3rd Edition | Keith Franklin | 9780123742445 | Academic Press , 2008 .

[64]  J. DeFelipe,et al.  The effects of morphine self-administration on cortical pyramidal cell structure in addiction-prone lewis rats. , 2006, Cerebral cortex.

[65]  M. Kathmann,et al.  Modulation of transmitter release via presynaptic cannabinoid receptors. , 2001, Trends in pharmacological sciences.

[66]  M. Parmentier,et al.  Cocaine, but not morphine, induces conditioned place preference and sensitization to locomotor responses in CB1 knockout mice , 2000, The European journal of neuroscience.

[67]  P. Robledo,et al.  Lack of CB1 Cannabinoid Receptor Impairs Cocaine Self-Administration , 2005, Neuropsychopharmacology.

[68]  K. Perry,et al.  The CB1 receptor antagonist SR141716A selectively increases monoaminergic neurotransmission in the medial prefrontal cortex: implications for therapeutic actions , 2003, British journal of pharmacology.

[69]  J. Pierri,et al.  Altered Cortical Glutamate Neurotransmission in Schizophrenia , 2003 .

[70]  N. Volkow,et al.  The neural basis of addiction: a pathology of motivation and choice. , 2005, The American journal of psychiatry.

[71]  K. Jin,et al.  Defective adult neurogenesis in CB1 cannabinoid receptor knockout mice. , 2004, Molecular pharmacology.